Skip to main content
Premium Trial:

Request an Annual Quote

Århus University, Eppendorf Array Technology, Gene Logic, University of Pittsburgh

Århus University of Århus, Denmark, has received European Patent No. 1875234, “Biosurface structure array.” The patent claims an array for testing different microenvironments for cultivation of cells or organisms. The array contains a number of testing areas on a metal surface. The testing areas may contain biomolecules including antibodies, antigens, glycoproteins, or DNA, the patent states. Users can use the array to compare the frequency of attachment of cells or organisms to any one tester area of the biosurface structure array; to compare the spread of cells or organisms on any one tester area of the array; or to compare differentiation of cells or organisms attached to any one tester area of the array.

Eppendorf Array Technology of Namur, Belgium, has received US Patent No. 7,321,829,Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips.” The patent describes a method for the identification or the quantification of a target compound obtained from a biological sample. The method includes the steps of: a) contacting the target compound with a capture molecule in order to allow a specific binding between the two; b) fixing the capture molecule on the surface of a solid support containing an array with at least 20 discrete regions; c) performing a reaction leading to a precipitate formed at the location of the binding, determining the possible presence of precipitates in the separate regions; and d) correlating the presence of the precipitates at the discrete regions with the identification and/or a quantification of the target compound.


Gene Logic of Gaithersburg, Md., and the University of Pittsburgh have received US Patent No. 7,321,830, “Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles.”The patent claims a computer system and database for elucidating changes in gene expression in prostate tissue isolated from patients exhibiting different clinical states of prostate hyperplasia as compared to normal prostate tissue, as well as the identification of individual genes that are differentially expressed in diseased prostate tissue.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.